Valuation: Ipca Laboratories Limited

Market Cap 498B 5.2B 4.56B 4.29B 3.92B 7.33B 7.38B 51.51B 19.97B 254B 19.52B 19.09B 823B P/E 2027 *
32.8x
P/E 2028 * 28.1x
Enterprise Value 487B 5.09B 4.46B 4.2B 3.84B 7.17B 7.22B 50.41B 19.54B 248B 19.1B 18.68B 805B EV / Sales 2027 *
4.43x
EV / Sales 2028 * 3.9x
Free-Float
54.94%
Yield 2027 *
0.29%
Yield 2028 * 0.32%
1 day-1.50%
1 week+0.61%
Current month-0.62%
1 month+2.69%
3 months+20.78%
6 months+28.28%
Current year+38.32%
1 week 1,948.5
Extreme 1948.5
2,038
1 month 1,905
Extreme 1905
2,038
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,251.6
Extreme 1251.6
2,038
3 years 885.65
Extreme 885.65
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%+0.61%+40.67%+119.47% 5.29B
-1.64%+1.16%+54.09%+109.07% 1,043B
-0.01%+0.71%+52.44%+67.71% 649B
-0.05%+0.98%+19.08%+73.55% 469B
-0.25%+0.19%+36.95%+45.63% 355B
+0.98%+2.91%+20.59%+27.91% 270B
-1.91%+2.42%+10.41%+12.53% 262B
-1.01%+7.90%+41.59%+51.70% 222B
-0.85%+2.50%+32.32%+101.80% 189B
-2.53%-7.47%-32.63%-60.67% 175B
Average -0.36%+1.58%+27.55%+54.87% 363.83B
Weighted average by Cap. +0.44%+1.34%+35.89%+65.93%

Financials

2027 *2028 *
Net sales 110B 1.15B 1.01B 947M 866M 1.62B 1.63B 11.38B 4.41B 56.06B 4.31B 4.22B 182B 123B 1.28B 1.12B 1.06B 966M 1.8B 1.82B 12.69B 4.92B 62.54B 4.81B 4.7B 203B
Net income 15.15B 158M 139M 130M 119M 223M 225M 1.57B 607M 7.72B 594M 581M 25.04B 17.8B 186M 163M 153M 140M 262M 264M 1.84B 714M 9.07B 698M 682M 29.42B
Net Debt -10.65B -111M -97.58M -91.73M -83.86M -157M -158M -1.1B -427M -5.43B -418M -408M -17.6B -19.96B -208M -183M -172M -157M -294M -296M -2.06B -800M -10.17B -782M -765M -32.99B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-09-23 ₹1,962.60 -1.50% 159,445
26-09-22 ₹1,992.40 -0.79% 122,345
26-09-21 ₹2,008.20 -0.07% 173,299
26-09-18 ₹2,009.60 +1.99% 527,501
26-09-17 ₹1,970.30 +1.00% 555,590
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,962.60INR
Average target price
1,972.28INR
Spread / Average Target
+0.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock